2025 / 06

Next Paper
DOI: 10.24075/brsmu.2025.080
Copyright: © 2025 by the authors. Licensee: Pirogov University.
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (CC BY).

ORIGINAL RESEARCH

Assessment of blood catecholamine and serotonin levels in anxiety and depressive disorders

Solovyova NV1 , Chuprova NA1 , Kochergina KV2 , Mitrofanov AA3 , Chausova SV4 , Kichuk IV4
About authors

1 Scientific Centre of Personalized Medicine, Moscow, Russia

2 Diagnostic and Treatment Center, Berezin Medical Institute, Moscow, Russia

3 Mental Health Research Center, Moscow, Russia

4 Pirogov Russian National Research Medical University, Moscow, Russia

Correspondence should be addressed: Irina V. Kichuk
Ostrovityanova, 1, Moscow, 119021, Russia; ur.liam@aniri2liam

About paper

Author contribution: Solovyova NV, Kichuk IV — study concept and design; Solovyova NV, Kochergina KV, Mitrofanov AA, Kichuk IV — material collection and processing; Chuprova NA, Kochergina KV — statistical data processing; Mitrofanov AA, Kichuk IV, Solovyova NV, Kochergina KV — manuscript writing; Mitrofanov AA, Kichuk IV, Solovyova NV, Kochergina KV, Chausova SV — editing.

Compliance with ethical standards: the study was approved by the Ethics Committee of the Joint Stock Company “Scientific Centre of Personalized Medicine” (protocol No. 33 dated 1 December 2025). The subjects’ personal data were hidden during the study. All the subjects submitted the informed consent for participation in the study.

Received: 2025-10-30 Accepted: 2025-12-08 Published online: 2025-12-19
|
  1. WHO. World mental health report: Transforming mental health for all. 2022.
  2. World Health Organization. The Global Burden of Disease. [cited 2024 Mar 24]. Available from: https://www.who.int/healthinfo/ global_burden_disease/estimates/en/index1.html.
  3. Lewinsohn PM, Shankman SA, Gau JM, Klein DN. The prevalence and co-morbidity of subthreshold psychiatric conditions. Psychol Med. 2004; 34 (4): 613–22. DOI: 10.1017/S0033291703001466.
  4. Chang C-K, Hayes RD, Perera G, Broadbent MTM, Fernandes AC, Lee WE, et al. Life Expectancy at Birth for People with Serious Mental Illness and Other Major Disorders from a Secondary Mental Health Care Case Register in London. PLoS One. 2011; 6 (5): Available from: e19590. DOI: 10.1371/journal.pone.0019590.
  5. Bachmann S. Epidemiology of Suicide and the Psychiatric Perspective. Int J Environ Res Public Health. 2018; 15(7): 1425. DOI: 10.3390/ijerph15071425.
  6. Mazo GM, Kasyanov ED, Kibitov AO. Mercayushchaya gran' mezhdu depressiej i trevogoj: klinicheskie i geneticheskie aspekty. Social'naya i klinicheskaya psihiatriya. 2022; 32 (4): 50–8. Russian.
  7. Neznanov NG, Martynihin IA, Mosolov SN. Diagnostika i terapiya trevozhnyh rasstrojstv v Rossijskoj Federacii: rezul'taty oprosa vrachej-psihiatrov. Sovremennaya terapiya psihicheskih rasstrojstv. 2017; 2: 2–13. Russian.
  8. Mosolov SN. Sovremennye biologicheskie gipotezy rekurrentnoj depressii (obzor). ZHurnal nevrologii i psihiatrii im. S. S. Korsakova. 2012; 122 (11–22): 29–40. Russian.
  9. Lee E-H, Han P-L. Reciprocal interactions across and within multiple levels of monoamine and cortico-limbic systems in stress-induced depression: A systematic review. Neurosci Biobehav Rev. 2019; 101: 13–31. DOI: 10.1016/j.neubiorev.2019.03.014.
  10. Wang L, Yang P, Yang C, Yang D, Wu X, Cao T, et al. Disturbance of neurotransmitter metabolism in drug-naïve, first-episode major depressive disorder: a comparative study on adult and adolescent cohorts. Eur Arch Psychiatry Clin Neurosci. 2022; 272 (7): 1283– 96. DOI: 10.1007/s00406-022-01406-8.
  11. Jeuring HW, D’Angremont E, Tol JMH, Risselada AJ, Sommer IEC, Oude Voshaar RC. The effectiveness of off-label dopamine stimulating agents in depressive disorder: A systematic review and meta-analysis. Psychiatry Res. 2023; 319: 115010. DOI: 10.1016/j.psychres.2022.115010.
  12. Kichuk IV, Petrova EA, Mitrofanov AA, Soloveva NV, Vilyanov VB. Izmeneniya pokazatelej elektroencefalogrammy i koncentracii serotonina pri depressivnyh i trevozhnyh rasstrojstvah. Nevrologiya, nejropsihiatriya, psihosomatika. 16AD; 8 (3): 34–8. Russian.
  13. Soloveva NV, Zvezdin VA, Urnyaeva SI, Mosova UV, Sokolov RV, Vilyanov VB. Soderzhanie biogennyh monoaminov v syvorotke krovi bol'nyh s endogennymi i ekzogennymi psihicheskimi rasstrojstvami. Akademicheskij zhurnal zapadnoj sibiri. 2013; 9 1 (44): 42–3. Russian.
  14. Solmi M, Cortese S, Vita G, De Prisco M, Radua J, Dragioti E, et al. An umbrella review of candidate predictors of response, remission, recovery, and relapse across mental disorders. Mol Psychiatry. 2023; 28 (9): 3671–87. DOI: 10.1038/s41380-023-02298-3.
  15. Li X, Fan Y, Xiao S, Peng S, Dong X, Zheng X, et al. Decreased platelet 5-hydroxytryptamin (5-HT) levels: a response to antidepressants. J Affect Disord. 2015; 187: 84–90. DOI: 10.1016/j.jad.2015.08.025.
  16. Pech J, Forman J, Kessing LV, Knorr U. Poor evidence for putative abnormalities in cerebrospinal fluid neurotransmitters in patients with depression versus healthy non-psychiatric individuals: A systematic review and meta-analyses of 23 studies. J Affect Disord. 2018; 240: 6–16. DOI: 10.1016/j.jad.2018.07.031.
  17. Esler M, Alvarenga M, Barton D, Jennings G, Kaye D, Guo L, et al. Measurement of Noradrenaline and Serotonin Metabolites With Internal Jugular Vein Sampling: An Indicator of Brain Monoamine Turnover in Depressive Illness and Panic Disorder. Front Psychiatry. 2022; 13. DOI: 10.3389/fpsyt.2022.818012.
  18. Pompili M, Lionetto L, Curto M, Forte A, Erbuto D, Montebovi F, et al. Tryptophan and Kynurenine Metabolites: Are They Related to Depression? Neuropsychobiology. 2019; 77(1): 23–8. DOI: 10.1159/000491604.
  19. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983; 67 (6): 361–70. DOI: 10.1111/j.1600-0447.1983.tb09716.x.
  20. Andryushchenko A. V., Drobizhev M. YU., Dobrovol'skij A. V. Sravnitel'naya ocenka shkal CES-D, BDI i HADS v diagnostike depressij v obshchemedicinskoj praktike. ZHurnal nevrologii i psihiatrii im. S. S. Korsakova. 2003; (5): 11–8.
  21. Kalisch R, Russo SJ, Müller MB. Neurobiology and systems biology of stress resilience. Physiol Rev. 2024. DOI: 10.1152/physrev.00042.2023.
  22. Bezrukov MV, Shilov YuE, Shestakova NV, Klyushnik TP. Biologicheskaya ocenka vyrazhennosti depressii: novyj metod opredeleniya koncentracii trombocitarnogo serotonina. ZHurnal nevrologii i psihiatrii im. S. S. Korsakova. 2014; 114 (8): 51–57. Russian.
  23. Kibitov AA, Rakitko AS, Kasyanov ED, Rukavishnikov GV, Kozlova KA, Ilinsky VV, et al. Screening of Depressive Symptoms in a Russian General Population Sample: A Web-based Cross-sectional Study. Clin Pract Epidemiol Ment Heal. 2021; 17 (1): 205–11. DOI: 10.2174/1745017902117010205.
  24. Morozova MA, Potanin SS, Beniashvili AG, Burminskij DS, Lepilkina TA, Rupchev GE, i dr. Validaciya russkoyazychnoj versii gospital'noj shkaly trevogi i depresii v obshchej populyacii. Profilakticheskaya medicina. 2023; 26 (4): 7–14.